BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15493353)

  • 1. Chaotic genomes make chaotic cells: the mutator phenotype theory of carcinogenesis applied to clinicopathological relationships of solid tumors.
    Bignold LP
    Cancer Invest; 2004; 22(3):338-43. PubMed ID: 15493353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of carcinogenesis: is the mutator phenotype inevitable?
    Beckman RA
    Semin Cancer Biol; 2010 Oct; 20(5):340-52. PubMed ID: 20934514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of genetic heterogeneity in cancer.
    Schmitt MW; Prindle MJ; Loeb LA
    Ann N Y Acad Sci; 2012 Sep; 1267():110-6. PubMed ID: 22954224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancers exhibit a mutator phenotype: clinical implications.
    Loeb LA; Bielas JH; Beckman RA
    Cancer Res; 2008 May; 68(10):3551-7; discussion 3557. PubMed ID: 18483233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic instability en route to and from cancer stem cells.
    Li L; Borodyansky L; Yang Y
    Cell Cycle; 2009 Apr; 8(7):1000-2. PubMed ID: 19270518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The population dynamics of cancer: a Darwinian perspective.
    Vineis P; Berwick M
    Int J Epidemiol; 2006 Oct; 35(5):1151-9. PubMed ID: 16987840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic instability in cancer: theory and experiment.
    Beckman RA; Loeb LA
    Semin Cancer Biol; 2005 Dec; 15(6):423-35. PubMed ID: 16043359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of human carcinogenesis.
    Coleman WB; Tsongalis GJ
    EXS; 2006; (96):321-49. PubMed ID: 16383025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutator phenotype theory can explain the complex morphology and behaviour of cancers.
    Bignold LP
    Cell Mol Life Sci; 2002 Jun; 59(6):950-8. PubMed ID: 12169025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of carcinogenesis with and without a mutator mutation.
    Beckman RA; Loeb LA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14140-5. PubMed ID: 16966602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutator phenotype in cancer: timing and perspectives.
    Bielas JH; Loeb LA
    Environ Mol Mutagen; 2005; 45(2-3):206-13. PubMed ID: 15672382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient appearance of the mutator phenotype during carcinogenesis as a possible explanation for the lack of mini/microsatellite instability in many late stage tumors.
    Stark AA
    Mutat Res; 1998 Nov; 421(2):221-5. PubMed ID: 9852996
    [No Abstract]   [Full Text] [Related]  

  • 13. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation.
    Tomasetti C; Vogelstein B; Parmigiani G
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):1999-2004. PubMed ID: 23345422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic changes in cancer.
    Iacobuzio-Donahue CA
    Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using passenger mutations to estimate the timing of driver mutations and identify mutator alterations.
    Youn A; Simon R
    BMC Bioinformatics; 2013 Dec; 14():363. PubMed ID: 24330428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutator hypothesis of carcinogenesis and supermutagens in anticancer therapy].
    Krutiakov VM
    Vestn Ross Akad Med Nauk; 2009; (9):39-43. PubMed ID: 19827641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific clones of spontaneously evolving karyotypes generate individuality of cancers.
    Fabarius A; Li R; Yerganian G; Hehlmann R; Duesberg P
    Cancer Genet Cytogenet; 2008 Jan; 180(2):89-99. PubMed ID: 18206533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic instability in human tumors.
    Raptis S; Bapat B
    EXS; 2006; (96):303-20. PubMed ID: 16383024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "aneuploidy-modified mutator-phenotype" theory of malignant tumors.
    Bignold LP
    Cell Oncol; 2008; 30(5):459. PubMed ID: 18791278
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenetic mechanisms of nuclear pleomorphism of tumour cells based on the mutator phenotype theory of carcinogenesis.
    Bignold LP
    Histol Histopathol; 2003 Apr; 18(2):657-64. PubMed ID: 12647815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.